WuXi AppTec (WUXAY) Projected to Release Quarterly Earnings on Monday

WuXi AppTec (OTCMKTS:WUXAY) is expected to release its resultson Monday, July 27th. Analysts expect WuXi AppTec to post earnings of $0.2321 per share and revenue of $1.9111 billion for the quarter.

WuXi AppTec (OTCMKTS:WUXAY) last posted its quarterly earnings data on Monday, April 27th. The company reported $0.23 EPS for the quarter, topping analysts’ consensus estimates of $0.18 by $0.05. The firm had revenue of $1.82 billion during the quarter, compared to the consensus estimate of $1.59 billion.

WuXi AppTec Stock Performance

Shares of WuXi AppTec stock opened at $19.53 on Monday. The business has a fifty day simple moving average of $17.46 and a 200-day simple moving average of $15.86. WuXi AppTec has a fifty-two week low of $11.52 and a fifty-two week high of $21.35.

Analysts Set New Price Targets

Separately, Zacks Research raised shares of WuXi AppTec to a “hold” rating in a report on Monday, April 13th. One investment analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, WuXi AppTec currently has an average rating of “Moderate Buy”.

WuXi AppTec Company Profile

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.